ENDONUCLEASE SYSTEMS
The present disclosure provides for endonuclease enzymes as well as methods of using such enzymes or variants thereof.
1 .- 170 . (canceled)
171 . An engineered nuclease system comprising:
(a) an endonuclease or a nucleic acid encoding said endonuclease, wherein said endonuclease comprises a sequence having at least 85% sequence identity to SEQ ID NO: 1316; and
(b) an engineered guide ribonucleic acid structure or a nucleic acid encoding said engineered guide ribonucleic acid structure, wherein said engineered guide ribonucleic acid structure is configured to form a complex with said endonuclease.
172 . The engineered nuclease system of claim 171 , wherein said engineered guide ribonucleic acid structure comprises:
(i) a guide ribonucleic acid sequence configured to hybridize to a target sequence; and
(ii) a tracr ribonucleic acid sequence configured to bind to said endonuclease.
173 . The engineered nuclease system of claim 172 , wherein said tracr ribonucleic acid sequence comprises a polynucleotide sequence having at least 80% sequence identity to SEQ ID NO: 200.
174 . The engineered nuclease system of claim 173 , wherein said tracr ribonucleic acid sequence comprises a polynucleotide sequence having at least 90% sequence identity to SEQ ID NO: 200.
175 . The engineered nuclease system of claim 174 , wherein said tracr ribonucleic acid sequence comprises a polynucleotide sequence of SEQ ID NO: 200.
176 . The engineered nuclease system of claim 171 , wherein said endonuclease further comprises one or more of: an arginine-rich region comprising an RRxRR motif (SEQ ID NO: 1361), a domain with PF14239 homology, a recognition (REC) domain, a bridge helix (BH) domain, a wedge (WED) domain, or a PAM interacting (PI) domain.
177 . The engineered nuclease system of claim 171 , wherein said endonuclease comprises one or more nuclear localization sequences (NLSs).
178 . The engineered nuclease system of claim 171 , wherein said endonuclease comprises a sequence having at least 90% sequence identity to SEQ ID NO: 1316.
179 . The engineered nuclease system of claim 178 , wherein said endonuclease comprises a sequence having at least 95% sequence identity to SEQ ID NO: 1316.
180 . The engineered nuclease system of claim 171 , wherein said endonuclease is an Archaeal endonuclease.
181 . The engineered nuclease system of claim 180 , wherein said endonuclease comprises a sequence having at least 95% sequence identity to SEQ ID NO: 1316.
182 . The engineered nuclease system of claim 171 , wherein said endonuclease comprises a sequence having less than 80% sequence identity to a Cas9 endonuclease.
183 . The engineered nuclease system of claim 171 , wherein said engineered guide ribonucleic acid structure comprises a sequence having at least 80% sequence identity to non-degenerate nucleotides of any one of SEQ ID NOs: 613, 615, or 616.
184 . The engineered nuclease system of claim 183 , wherein said engineered guide ribonucleic acid structure comprises a sequence having at least 90% sequence identity to non-degenerate nucleotides of any one of SEQ ID NOs: 613, 615, or 616.
185 . The engineered nuclease system of claim 184 , wherein said engineered guide ribonucleic acid structure comprises non-degenerate nucleotides any one of SEQ ID NOs: 613, 615, or 616.
186 . The engineered nuclease system of claim 172 , wherein said engineered guide ribonucleic acid structure comprises:
(a) at least two ribonucleic acid polynucleotides; or (b) a single ribonucleic acid polynucleotide comprising said guide ribonucleic acid sequence and said tracr ribonucleic acid sequence.
187 . The engineered nuclease system of claim 172 , wherein said guide ribonucleic acid sequence is complementary to a eukaryotic, a fungal, a plant, a mammalian, or a human genomic sequence.
188 . The engineered nuclease system of claim 171 , further comprising a single-stranded or double-stranded deoxyribonucleic acid repair template.
189 . The engineered nuclease system of claim 188 , wherein said single-stranded or double-stranded deoxyribonucleic acid repair template comprises a transgene donor.
190 . The engineered nuclease system of claim 171 , wherein said sequence identity is determined by a BLASTP homology search algorithm using parameters of a wordlength (W) of 3, an expectation (E) of 10, and a BLOSUM62 scoring matrix setting gap costs at existence of 11, extension of 1, and using a conditional compositional score matrix adjustment.